468 related articles for article (PubMed ID: 19642149)
21. Oral anticoagulant therapy in patients with atrial fibrillation.
Pengo V
Semin Vasc Med; 2003 Aug; 3(3):333-8. PubMed ID: 15199467
[TBL] [Abstract][Full Text] [Related]
22. Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment.
Poli D; Antonucci E; Grifoni E; Abbate R; Gensini GF; Prisco D
Thromb Haemost; 2009 May; 101(5):938-42. PubMed ID: 19404548
[TBL] [Abstract][Full Text] [Related]
23. Between the Devil and the Deep Blue Sea--balancing the risks and potential benefits of warfarin for older people with atrial fibrillation.
Morgan SV
Age Ageing; 2004 Nov; 33(6):544-7. PubMed ID: 15501835
[No Abstract] [Full Text] [Related]
24. Stroke risk in atrial fibrillation patients on warfarin. Predictive ability of risk stratification schemes for primary and secondary prevention.
Poli D; Antonucci E; Grifoni E; Abbate R; Gensini GF; Prisco D
Thromb Haemost; 2009 Feb; 101(2):367-72. PubMed ID: 19190823
[TBL] [Abstract][Full Text] [Related]
25. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].
Själander A; Wallentin L; Rosenqvist M; Svensson P
Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862
[No Abstract] [Full Text] [Related]
26. Stroke prevention in nonvalvular atrial fibrillation.
Ganjehei L; Massumi A; Razavi M; Rasekh A
Tex Heart Inst J; 2011; 38(4):350-2. PubMed ID: 21841857
[No Abstract] [Full Text] [Related]
27. Overview of the Food and Drug Administration circulatory system devices panel meetings on WATCHMAN left atrial appendage closure therapy.
Waksman R; Pendyala LK
Am J Cardiol; 2015 Feb; 115(3):378-84. PubMed ID: 25579887
[TBL] [Abstract][Full Text] [Related]
28. Percutaneous devices for stroke prevention.
Bayard YL; Ostermayer SH; Hein R; Skowasch M; Büscheck F; Baranowski A; Heinisch C; Sievert H
Cardiovasc Revasc Med; 2007; 8(3):216-25. PubMed ID: 17765654
[TBL] [Abstract][Full Text] [Related]
29. Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a Phase II study of AZD0837 in patients who are appropriate for but unable or unwilling to take vitamin K antagonist therapy.
Lip GY; Rasmussen LH; Olsson SB; Zetterstrand S; Stahre C; Bylock A; Aunes-Jansson M; Eriksson U; Wåhlander K;
Thromb Res; 2011 Feb; 127(2):91-9. PubMed ID: 21172721
[TBL] [Abstract][Full Text] [Related]
30. Left atrial appendage closure for stroke prevention in atrial fibrillation: state of the art and current challenges.
Syed TM; Halperin JL
Nat Clin Pract Cardiovasc Med; 2007 Aug; 4(8):428-35. PubMed ID: 17653115
[TBL] [Abstract][Full Text] [Related]
31. Left atrial appendage exclusion: An alternative to anticoagulation in nonvalvular atrial fibrillation.
Bedeir K; Holmes DR; Cox JL; Ramlawi B
J Thorac Cardiovasc Surg; 2017 May; 153(5):1097-1105. PubMed ID: 28262290
[No Abstract] [Full Text] [Related]
32. What's your stroke risk after atrial fibrillation? Novel risk-scoring method is precise but not perfect.
Carlson MD
Health News; 2003 Nov; 9(11):4-5. PubMed ID: 14619811
[No Abstract] [Full Text] [Related]
33. Warfarin and stroke outcomes in hemodialysis patients with atrial fibrillation.
Genovesi S; Santoro A
J Am Soc Nephrol; 2009 Oct; 20(10):2090-2. PubMed ID: 19713302
[No Abstract] [Full Text] [Related]
34. Percutaneous left atrial appendage transcatheter occlusion in patients with chronic nonvalvular atrial fibrillation: early institutional experience.
Ussia GP; Mangiafico S; Privitera A; Mulè M; Caruso E; Galassi AR; Famoso G; Tamburino C
J Cardiovasc Med (Hagerstown); 2006 Aug; 7(8):569-72. PubMed ID: 16858233
[TBL] [Abstract][Full Text] [Related]
35. Atrial fibrillation and stroke risk prevention in real-life clinical practice.
Tay KH; Lip GY; Lane DA
Thromb Haemost; 2009 Mar; 101(3):415-6. PubMed ID: 19277398
[No Abstract] [Full Text] [Related]
36. Chronic renal disease and stroke in atrial fibrillation: balancing the prevention of thromboembolism and bleeding risk.
Lip GY
Europace; 2011 Feb; 13(2):145-8. PubMed ID: 21138929
[No Abstract] [Full Text] [Related]
37. The association of warfarin use with osteoporotic fracture in elderly patients with atrial fibrillation.
Cheng HY
Arch Intern Med; 2006 Jul; 166(14):1525; author reply 1525. PubMed ID: 16864765
[No Abstract] [Full Text] [Related]
38. Identifying AF patients at risk of stroke: can prothrombotic indices improve things?
Watson T; Lip GY
Int J Cardiol; 2008 Jun; 126(3):299-301. PubMed ID: 18077017
[No Abstract] [Full Text] [Related]
39. Will warfarin soon be passé? New approaches to stroke prevention in atrial fibrillation.
Hammwöhner M; Goette A
J Cardiovasc Pharmacol; 2008 Jul; 52(1):18-27. PubMed ID: 18594479
[TBL] [Abstract][Full Text] [Related]
40. Percutaneous closure of the left atrial appendage: a major step forward.
Sievert H; Bayard YL
JACC Cardiovasc Interv; 2009 Jul; 2(7):601-2. PubMed ID: 19628180
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
